Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that leads to memory loss, confusion, and changes in behavior, significantly impacting daily life.
THN391 for Early Alzheimer's Disease
We are testing a new medication to see if it is safe and well-tolerated in people with early Alzheimer's disease. This study will help us understand how the drug works in the body.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC Stichting
Alzheimer Center Amsterdam, Dept. Neurology
Amstelveen, Netherlands
CTC Netherlands B.V.
Groningen, Netherlands
Sponsor: Therini Bio Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.